• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补充和替代医学在肿瘤学中的应用:患者和医疗保健专业人员的问卷调查。

Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals.

机构信息

Department of Surgery, University College Hospital Galway, National University of Ireland.

出版信息

BMC Cancer. 2011 May 24;11:196. doi: 10.1186/1471-2407-11-196.

DOI:10.1186/1471-2407-11-196
PMID:21609461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3123324/
Abstract

BACKGROUND

We aimed to investigate the prevalence and predictors of Complementary and Alternative Medicine (CAM) use among cancer patients and non-cancer volunteers, and to assess the knowledge of and attitudes toward CAM use in oncology among health care professionals.

METHODS

This is a cross-sectional questionnaire survey conducted in a single institution in Ireland. Survey was performed in outpatient and inpatient settings involving cancer patients and non-cancer volunteers. Clinicians and allied health care professionals were asked to complete a different questionnaire.

RESULTS

In 676 participants including 219 cancer patients; 301 non-cancer volunteers and 156 health care professionals, the overall prevalence of CAM use was 32.5% (29.1%, 30.9% and 39.7% respectively in the three study cohorts). Female gender (p < 0.001), younger age (p = 0.004), higher educational background (p < 0.001), higher annual household income (p = 0.001), private health insurance (p = 0.001) and non-Christian (p < 0.001) were factors associated with more likely CAM use. Multivariate analysis identified female gender (p < 0.001), non-Christian (p = 0.001) and private health insurance (p = 0.015) as independent predictors of CAM use. Most health care professionals thought they did not have adequate knowledge (58.8%) nor were up to date with the best evidence (79.2%) on CAM use in oncology. Health care professionals who used CAM were more likely to recommend it to patients (p < 0.001).

CONCLUSIONS

This study demonstrates a similarly high prevalence of CAM use among oncology health care professionals, cancer and non cancer patients. Patients are more likely to disclose CAM usage if they are specifically asked. Health care professionals are interested to learn more about various CAM therapies and have poor evidence-based knowledge on specific oncology treatments. There is a need for further training to meet to the escalation of CAM use among patients and to raise awareness of potential benefits and risks associated with these therapies.

摘要

背景

我们旨在调查癌症患者和非癌症志愿者中补充和替代医学(CAM)的使用情况及其预测因素,并评估肿瘤学中医疗保健专业人员对 CAM 使用的了解和态度。

方法

这是在爱尔兰的一家单一机构进行的横断面问卷调查。调查在门诊和住院环境中进行,涉及癌症患者和非癌症志愿者。临床医生和辅助医疗保健专业人员被要求填写不同的问卷。

结果

在 676 名参与者中,包括 219 名癌症患者;301 名非癌症志愿者和 156 名医疗保健专业人员,CAM 使用的总体流行率为 32.5%(三个研究队列中的分别为 29.1%、30.9%和 39.7%)。女性(p < 0.001)、年龄较小(p = 0.004)、较高的教育背景(p < 0.001)、较高的家庭年收入(p = 0.001)、私人医疗保险(p = 0.001)和非基督教徒(p < 0.001)是 CAM 使用可能性更大的相关因素。多变量分析确定女性(p < 0.001)、非基督教徒(p = 0.001)和私人医疗保险(p = 0.015)是 CAM 使用的独立预测因素。大多数医疗保健专业人员认为他们没有足够的知识(58.8%),也没有跟上关于肿瘤学中 CAM 使用的最佳证据(79.2%)。使用过 CAM 的医疗保健专业人员更有可能向患者推荐(p < 0.001)。

结论

本研究表明,肿瘤学医疗保健专业人员、癌症患者和非癌症患者中 CAM 使用的流行率相似较高。如果专门询问,患者更有可能透露他们使用 CAM。医疗保健专业人员有兴趣了解更多各种 CAM 疗法,并且对特定的肿瘤学治疗方法缺乏基于证据的知识。需要进一步的培训来满足患者中 CAM 使用的增加,并提高对这些疗法相关潜在益处和风险的认识。

相似文献

1
Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals.补充和替代医学在肿瘤学中的应用:患者和医疗保健专业人员的问卷调查。
BMC Cancer. 2011 May 24;11:196. doi: 10.1186/1471-2407-11-196.
2
Knowledge and beliefs concerning evidence-based practice amongst complementary and alternative medicine health care practitioners and allied health care professionals: a questionnaire survey.补充与替代医学保健从业者及相关卫生保健专业人员对循证医学的认知与信念:一项问卷调查
BMC Complement Altern Med. 2008 Jul 23;8:45. doi: 10.1186/1472-6882-8-45.
3
Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients.德国姑息医学协会成员对癌症患者补充和替代医学的态度。
J Cancer Res Clin Oncol. 2014 Jul;140(7):1229-37. doi: 10.1007/s00432-014-1656-9. Epub 2014 Apr 6.
4
Attitude of employees of a university clinic to complementary and alternative medicine in oncology.大学诊所员工对肿瘤学补充和替代医学的态度。
Ann Oncol. 2013 Oct;24(10):2641-2645. doi: 10.1093/annonc/mdt299. Epub 2013 Aug 13.
5
Cross-sectional survey on complementary and alternative medicine awareness among health care professionals and students using CHBQ questionnaire in a Balkan country.在巴尔干国家,使用 CHBQ 问卷对医护人员和学生进行补充和替代医学认知的横断面调查。
Chin J Integr Med. 2013 Sep;19(9):650-5. doi: 10.1007/s11655-013-1434-6. Epub 2013 Aug 24.
6
Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey.关于补充和替代医学的态度与信念是否会影响癌症患者对其的使用?一项横断面调查。
Cancer. 2015 Jul 15;121(14):2431-8. doi: 10.1002/cncr.29173. Epub 2015 May 26.
7
Attitudes toward complementary and alternative medicine amongst oncology professionals in Brazil.巴西肿瘤学专业人员对补充和替代医学的态度。
Complement Ther Med. 2016 Aug;27:30-4. doi: 10.1016/j.ctim.2016.04.003. Epub 2016 May 6.
8
Investigation of usage, attitudes toward complementary and alternative medicine among cancer patients in Turkey during the COVID-19 pandemic1.1. 新冠疫情大流行期间土耳其癌症患者对补充替代医学的使用和态度调查
Work. 2024;78(4):1161-1172. doi: 10.3233/WOR-230195.
9
Trends in use of complementary and alternative medicine by US adults: 1997-2002.1997 - 2002年美国成年人使用补充和替代医学的趋势。
Altern Ther Health Med. 2005 Jan-Feb;11(1):42-9.
10
Complementary health therapies: moving towards an integrated health model.补充性健康疗法:迈向综合健康模式。
Collegian. 2013;20(1):51-60. doi: 10.1016/j.colegn.2012.03.004.

引用本文的文献

1
Effects of blended learning training for oncology physicians to advise their patients about complementary and integrative therapies: results from the multicenter cluster-randomized KOKON-KTO trial.肿瘤医师接受补充与整合医学咨询培训的效果:来自多中心、集群随机对照 KOKON-KTO 试验的结果。
BMC Cancer. 2023 Sep 7;23(1):836. doi: 10.1186/s12885-023-11348-6.
2
Perception, attitudes, knowledge of using complementary and alternative medicine for cancer patients among healthcare professionals: A mixed-methods systematic review.医疗保健专业人员对癌症患者使用补充和替代医学的认知、态度及知识:一项混合方法的系统评价
Cancer Med. 2023 Sep;12(18):19149-19162. doi: 10.1002/cam4.6499. Epub 2023 Sep 7.
3
Endorsement of alternative medicine and vaccine hesitancy among physicians: A cross-sectional study in four European countries.医生对替代医学的认可和疫苗犹豫:四个欧洲国家的横断面研究。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2242748. doi: 10.1080/21645515.2023.2242748.
4
Attitude of healthcare professionals toward the use of complementary and alternative medication during anti-cancer therapy.医疗保健专业人员对抗癌治疗期间使用补充和替代药物的态度。
J Oncol Pharm Pract. 2024 Jun;30(4):628-635. doi: 10.1177/10781552231179899. Epub 2023 May 31.
5
Perspectives and Attitudes of Dutch Healthcare Professionals Regarding the Integration of Complementary Medicine in Oncology.荷兰医疗保健专业人员对肿瘤学中补充医学整合的观点和态度。
Integr Cancer Ther. 2023 Jan-Dec;22:15347354231164650. doi: 10.1177/15347354231164650.
6
Cancer Patient Motives and Expectations on Non-medical Practitioners.癌症患者对非医疗从业者的动机和期望。
In Vivo. 2022 Sep-Oct;36(5):2505-2513. doi: 10.21873/invivo.12986.
7
Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey.尼泊尔癌症患者中传统和补充医学的使用情况:一项横断面调查。
BMC Complement Med Ther. 2022 Mar 15;22(1):70. doi: 10.1186/s12906-022-03555-8.
8
Acceptance and use of complementary and alternative medicine among medical specialists: a 15-year systematic review and data synthesis.医学专家对补充替代医学的接受和使用:一项 15 年的系统评价和数据综合分析。
Syst Rev. 2022 Jan 14;11(1):10. doi: 10.1186/s13643-021-01882-4.
9
A pre-post evaluation of oncology healthcare providers' knowledge, attitudes, and practices following the implementation of a complementary medicine practice guideline.实施补充医学实践指南后对肿瘤医护人员的知识、态度和实践进行的前后评估。
Support Care Cancer. 2021 Dec;29(12):7487-7495. doi: 10.1007/s00520-021-06318-2. Epub 2021 Jun 7.
10
Perceptions of homeopathy in supportive cancer care among oncologists and general practitioners in France.法国肿瘤学家和全科医生对顺势疗法在癌症支持性护理中的看法。
Support Care Cancer. 2021 Oct;29(10):5873-5881. doi: 10.1007/s00520-021-06137-5. Epub 2021 Mar 24.

本文引用的文献

1
Complementary alternative medicine (CAM) use in Ireland: a secondary analysis of SLAN data.爱尔兰的补充替代医学(CAM)使用情况:SLAN 数据的二次分析。
Complement Ther Med. 2010 Apr;18(2):95-103. doi: 10.1016/j.ctim.2010.02.001. Epub 2010 Mar 1.
2
Complementary medicine use in patients with head and neck cancer in Ireland.爱尔兰头颈部癌症患者的补充医学应用。
Eur Arch Otorhinolaryngol. 2010 Aug;267(8):1291-7. doi: 10.1007/s00405-010-1223-1. Epub 2010 Mar 14.
3
Do cancer patients with a poor prognosis use complementary and alternative medicine more often than others?预后较差的癌症患者比其他患者更常使用补充和替代医学吗?
J Altern Complement Med. 2009 Jan;15(1):35-40. doi: 10.1089/acm.2008.0262.
4
The use of herbal medicines by people with cancer: a qualitative study.癌症患者使用草药的情况:一项定性研究。
BMC Complement Altern Med. 2009 May 14;9:14. doi: 10.1186/1472-6882-9-14.
5
Patterns of complementary and alternative medicine use among patients undergoing cancer treatment.癌症治疗患者中补充和替代医学的使用模式。
Eur J Cancer Care (Engl). 2009 May;18(3):271-9. doi: 10.1111/j.1365-2354.2007.00911.x.
6
Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients.新加坡成年癌症患者使用补充和替代医学(CAM)的情况。
Ann Oncol. 2009 Apr;20(4):752-7. doi: 10.1093/annonc/mdn659. Epub 2009 Jan 15.
7
A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors.一项基于人群的癌症幸存者使用补充疗法的患病率研究:美国癌症协会癌症幸存者研究报告。
Cancer. 2008 Sep 1;113(5):1048-57. doi: 10.1002/cncr.23659.
8
Psychological and behavioral mechanisms influencing the use of complementary and alternative medicine (CAM) in cancer patients.影响癌症患者使用补充和替代医学(CAM)的心理及行为机制。
Ann Oncol. 2008 Jan;19(1):49-55. doi: 10.1093/annonc/mdm494. Epub 2007 Oct 26.
9
Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.参加I期试验的晚期癌症患者的补充和替代医学:一项关于预后、生活质量及决策偏好的研究。
J Clin Oncol. 2007 Feb 10;25(5):548-54. doi: 10.1200/JCO.2005.03.9800.
10
Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia.二十碳五烯酸(EPA,一种来自鱼油的ω-3脂肪酸)用于治疗癌症恶病质。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004597. doi: 10.1002/14651858.CD004597.pub2.